Granules India invests additional $20 million in Granules Pharmaceuticals

30 Jan 2017 Evaluate

Granules India has received an approval for further investment of $20 million in Granules Pharmaceuticals Inc., a wholly owned subsidiary of the company. The board of directors at its meeting held on January 28, 2017 has approved for the same.

Granules India is a pharmaceutical company with presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs).


Granules India Share Price

564.95 -6.25 (-1.09%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×